Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2019.10844 mmr-21-01-0201 Articles Mitochondrial tRNAAla 5601C>T variant may affect the clinical expression of the LHON-related ND4 11778G>A mutation in a family DingYu 1 YeYu-Feng 2 LiMei-Ya 3 XiaBo-Hou 4 LengJian-Hang 1 Central Laboratory, School of Medicine, Hangzhou First People's Hospital, Zhejiang University, Hangzhou, Zhejiang 310006, P.R. China Department of Ophthalmology, School of Medicine, Hangzhou First People's Hospital, Zhejiang University, Hangzhou, Zhejiang 310006, P.R. China Analytical Testing Center, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China Department of Pharmacy, Hunan Chinese Medical University, Changsha, Hunan 410208, P.R. China Correspondence to: Dr Jian-Hang Leng, Central Laboratory, School of Medicine, Hangzhou First People's Hospital, Zhejiang University, 261 Huansha Road, Hangzhou, Zhejiang 310006, P.R. China, E-mail: lengjh5@163.com 012020 22112019 21 1 201 208 02052019 09102019 Copyright: © Ding et al. 2020 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Certain mutations in mitochondrial DNA (mtDNA) are associated with Leber's hereditary optic neuropathy (LHON). In particular, the well-known NADH dehydrogenase 4 (ND4) m.11778G>A mutation is one of the most common LHON-associated primary mutations worldwide. However, how specific mtDNA mutations, or variants, affect LHON penetrance is not fully understood. The aim of the current study was to explore the relationship between mtDNA mutations and LHON, and to provide useful information for early detection and prevention of this disease. Following the molecular characterization of a Han Chinese family with maternally inherited LHON, four out of eight matrilineal relatives demonstrated varying degrees of both visual impairment and age of onset. Through PCR amplification of mitochondrial genomes and direct Sanger sequencing analysis, a homoplasmic mitochondrial-encoded ND4 m.11778G>A mutation, alongside a set of genetic variations belonging to human mtDNA haplogroup B5b1 were identified. Among these sequence variants, alanine transfer RNA (tRNA)Ala m.5601C>T was of particular interest. This variant occurred at position 59 in the TψC loop and altered the base pairing, which led to mitochondrial RNA (mt-RNA) metabolism failure and defects in mitochondrial protein synthesis. Bioinformatics analysis suggested that the m.5601C>T variant altered tRNAAla structure. Therefore, impaired mitochondrial functions caused by the ND4 m.11778G>A mutation may be enhanced by the mt-tRNAAla m.5601C>T variant. These findings suggested that the tRNAAla m.5601C>T variant might modulate the clinical manifestation of the LHON-associated primary mutation.

 mitochondrial DNA Leber's hereditary optic neuropathy m.11778G>A m.5601C>T alanine transfer RNA Introduction

Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease that affects 1 in 31,000-50,000 people and culminates in the bilateral loss of central vision (1–3). In the North East of England, it has been reported that 1:8,500 individuals harbor a primary LHON-causing mutation and 1:31,000 experience visual loss as a result of LHON (4). Patients with LHON may exhibit abnormal symptoms, including movement disorders, dystonia or multiplesclerosislike symptoms, which pose a significant challenge for clinicians (5,6). Few significant improvements in visual acuity are reported following atrophy of the optic discs. LHON demonstrates an incomplete penetrance for both vision loss and gender bias; LHON affects males more frequently than females (7,8). Three primary mutations including the NADH dehydrogenase (ND) 4 m.11778G>A, ND6 m.14484T>C and ND1 m.3460G>A have been identified in 90% of patients with LHON (9–11). Yet the molecular mechanisms of these mtDNA mutations in the phenotypic manifestation of LHON have not been elucidated.

To understand the role of mitochondrial dysfunction in LHON, an extended genetic screen for mtDNA variants was performed in a Han Chinese family with a high prevalence of LHON. Sequence analysis of the complete mitochondrial genome identified the occurrence of an ND4 m.11778G>A mutation and an alanine transfer RNA (tRNAAla) m.5601C>T variant within matrilineal relatives of the proband. In addition, bioinformatics analysis was performed in order to explore whether the m.5601C>T affected the tRNAAla secondary structure.

 Patients and methods <sec> <title>Patients and genetic screening

To identify mtDNA variations in Chinese patients with LHON, a Han Chinese family was recruited from Hangzhou First People's Hospital (Hangzhou, China) in January 2018, and blood samples (5 ml) were collected from each matrilineal relative of the proband. Blood samples (5 ml) from unrelated control subjects (n=300) from the same geographical region recruited at the Hangzhou First People's Hospital were also used in the present study. These healthy subjects consisted of 200 males and 100 females, aged 11–48 years, and were enrolled from January 2018 to January 2019. The present study was approved by the Ethics Committee of Hangzhou First People's Hospital. Written informed consent was obtained from all participants, or their parent/guardian, prior to enrollment in the study.

 Clinical examinations

The proband (II-12) and other affected matrilineal relatives (II-5, II-7 and III-8; Fig. 1) underwent comprehensive ophthalmic examinations, including visual field tests, examination of visual acuity, fundus photography, visual evoked potentials and determination of the degree of visual impairment, performed as previously described (12,13). The degree of visual impairment was classified based on the following criteria (12,13): healthy, ≥0.300; mild, 0.100–0.299; moderate, 0.050–0.099; severe, 0.020–0.049; and profound, <0.020.

 PCR and genetic sequencing to identify mtDNA variants

Genomic DNA from LHON patients and control subjects was extracted using a DNA extraction kit (QIAamp® DNA Blood Mini kit; Qiagen GmbH), according to the manufacturer's protocol. The complete mitochondrial genomes of II-5, II-7, II-12 and III-8 were amplified in 24 overlapping fragments using 200 µM dNTP, 10X buffer, Taq DNA polymerase and 15 mmol/l Mg2 (cat. no. R004A; Takara Biotechnology, Co., Ltd.). The 24 sequences of light-strand and heavy-strands oligonucleotide primers for amplification of mtDNA genes were used according to a previous report (14). The following thermocycling conditions were used for PCR: 95°C for 5 min; 30 cycles of 94°C for 10 sec, 60°C for 30 sec and 72°C for 1 min; and a final extension at 72°C for 5 min. After confirmation of band of interest, the PCR products were purified using the PureLink Gel Extraction kit (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's recommendations. DNA samples with concentrations >1.0 ng/µl were sequenced using the BigDye™ Terminator Cycle Sequencing reaction kit (Applied Biosystems; Thermo Fisher Scientific, Inc.) and an ABI PRISM® 3700 DNA Analyzer. Sequencing data were compared with the updated Cambridge consensus human mitochondrial genome sequence (accession no. NC_012920) using DNASTAR version 5.01 (DNASTAR Inc.) (15).

 Phylogenetic conservation analysis

Phylogenetic analysis was performed to determine the potential pathogenic role of the identified mtDNA mutations. Briefly, 17 different species were selected for phylogenetic analysis (Table I). The conservation index (CI) was measured by comparing the human nucleotide alternations with the nucleotide sequences of other species. CI≥70% was implicated to have functional significance (16).

 Bioinformatics analysis

To determine whether the m.5601C>T variant affected tRNAAla secondary structure, the RNAfold web server program was used (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi), as previously described (17).

 Determining the pathogenicity of the variant

The role of the tRNAAla m.5601C>T variant was determined using the pathogenicity scoring system, as described by Yarham et al (18). In brief, mutations were classified as: ‘neutral polymorphism’, ≤6; ‘possible pathogenic’, 7–10; ‘definitely pathogenic’, ≥11.

 Statistical analysis

SPSS 17.0 software (SPSS Inc.) was used for statistical analysis. Fisher's exact test was used to assess the differences between groups. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Clinical presentation of a Han Chinese family with LHON

A pedigree chart from a Han Chinese family with a history of LHON is presented in Fig. 1. There were four LHON patients presented in the pedigree (three males and one female), aged 7–39 years old. Medical history analysis of the proband (II-12) confirmed that no other clinical disorders, such as deafness, diabetes mellitus, cardiovascular diseases, cancer or neurological disorders, were present. Following comprehensive genetic counseling at the Department of Ophthalmology in Hangzhou First People's Hospital, the proband (age, 39), was found to have begun suffering from painless and progressive bilateral loss of vision at the age of 19, manifesting as a dark cloud in the central vision and difficulty differentiating different colors. Ophthalmic examination revealed large centrocecal scotoma in both eyes, a typical clinical feature of LHON (13). A total of three out of seven matrilineal relatives (II-5, II-7 and III-8), in addition to the proband (II-12), suffered from moderate to profound visual impairment (Table II).

 Screening for mtDNA mutations

To investigate the molecular basis of LHON, II-5, II-7, II-12 and III-8 were screened for mutations following PCR amplification of the mtDNA genomes. Sequence analysis of the mtDNA PCR products revealed 32 genetic polymorphisms (Table III), all of which belonged to the human mtDNA B5b1 haplogroup (19). Of these, there were nine variants in the D-loop gene, two variants in the 12S rRNA gene, one variant in the 16S rRNA gene and one variant in a tRNA gene (m.5601C>T). The other variants were mainly localized within oxidative phosphorylation encoding genes. Notably, five missense mutations were identified: Mitochondrial encoded NADH dehydrogenase 1 (ND1) m.3593T>C (p.V96A), ND2 m.5442T>C (p.F325L), ATP 6 m.9103T>C (p.F193L), ND3 m.10398A>G (p.T114A) and ND4 m.11778G>A (p.R340H). The CIs of these variants were investigated between different species, including mouse, bovine and Xenopus laevis (20–22). Of all identified variants, only tRNAAla m.5601C>T and ND4 m.11778G>A were conserved. Notably, the m.5601C>T and m.11778G>A mutations were absent in the 300 control subjects compared with the mtDNA genomes of the matrilineal relatives (P<0.05). Taken together, these results indicated that tRNAAla m.5601C>T and ND4 m.11778G>A may have active roles in the pathogenesis of LHON.

In addition, the results revealed that the ratio between affected males and females carrying ND4 m.11778G>A mutations in this case study was 3:1, which was similar to previous studies on families with LHON carrying ND4 m.11778G>A mutations (Table IV) (23–28). These findings suggested that the m.11778G>A mutation may be the molecular basis for the LHON phenotype.

 m.5601C>T variant alters the tRNA<sup>Ala</sup> structure

The m.5601C>T variant is located at a highly conserved position in the TψC loop within the tRNAAla (29); thus, the point mutation results in a missense mutation that creates a novel base pairing (55T-59C) (Figs. 2 and 3). Subsequent bioinformatics analysis revealed that the m.5601C>T variant caused a structural alteration of tRNAAla (Fig. 4), which indicated that m.5601C>T may have an impact on tRNAAla function.

 m.5601C>T variant is ‘possibly pathogenic’ for LHON

The pathogenicity scoring system described by Yarham et al (18) was used to determine the role of the tRNAAla m.5601C>T variant. As presented in Table V, the total pathogenicity score for the m.5601C>T variant was 8, placing it within the ‘possibly pathogenic’ category for LHON.

 Discussion

In the present study, a Han Chinese family with maternally inherited LHON was clinically and molecularly characterized. One of the most common features of LHON is bilateral loss of vision in the matrilineal relatives of the proband (9); this preferential effect on vision has facilitated the positive association between mtDNA mutations and LHON (30). Clinical evaluation of this family revealed that the age of onset for visual impairment between 3 and 19 years. The association between m. 11778G>A and LHON was reported as early as 1988 (31). In the present study, patients harboring the m.11778G>A mutation had different mtDNA haplogroups, suggesting that the m.11778G>A mutation occurred sporadically and multiplied through evolution of the mtDNA in China. The varying degree of visual impairment in this Chinese family suggested that modifying factors, such as nuclear genes, environmental factors and mitochondrial genetic polymorphisms, may also contribute to LHON penetrance (32). In particular, secondary LHON-associated variants, such as ND1 m.4216T>C and ND5 m.13708G>A mutations in the mtDNA haplogroup J, may increase the penetrance and severity of LHON, in combination with the primary mutations, in European populations (33). mtDNA haplogroups M7b1′2 and M8a have been implicated in the clinical expression of the LHON-associated ND4 m.11778G>A mutation (33).

In the present study, sequencing of the complete mitochondrial genomes of the matrilineal relatives (II-5, II-7, II-12 and III-8) revealed a set of genetic polymorphisms from the Asian mtDNA haplogroup B5b1 (19). Of these variants, tRNAAla m.5601C>T was of most interest because this variant is located at a highly conserved nucleotide in the TψC loop of tRNAAla (position 59), which is thought to be involved in tertiary interactions between the TψC loop and the truncated D-arm (34). Bioinformatics analysis revealed that the m.5601C>T variant created a novel Watson-Crick base-pairing (55T-59C). The tRNAAla m.5601C>T variant has previously been associated with maternally inherited hypertension and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (35,36). Therefore, the m.5601C>T may alter the secondary structure of tRNAAla and impair the mt-tRNA metabolism and protein translation, and contribute to the LHON phenotype. A previous study has demonstrated that the m.12192G>A mutation, occurring at a similar position on tRNAHis, modulates the clinical expression of deafness in a Chinese pedigree (37), whereas the m.5601C>T variant may increase the penetrance of the hypertension-associated tRNAMet m.4435A>G mutation (35). Zhou et al have previously described the association between the tRNAAla m.5601C>T variant and LHON in seven Han Chinese families (38). However, these families only carried the m.5601C>T variant, and did not harbor the three LHON-associated primary mutations (ND4 m.11778G>A, ND6 m.14484T>C and ND1 m.3460G>A), thus exhibiting very low penetrance and severity of visual impairment (4.5–25.0%) (38). In the present study, the penetrance of LHON-induced visual impairment was 40%, which suggested that the combination of the ND4 m.11778G>A mutation and the tRNAAla m.5601C>T variant may be responsible for the higher prevalence of LHON in this family.

Results from the present study suggested that the tRNAAla m.5601C>T variant could increase both the prevalence and the expression of the LHON-associated ND4 m.11778G>A mutation. Evidence to support this includes the fact that the mutation occurs at a highly conserved nucleotide of tRNAAla, which is critical for basal tRNA activity and normal function (29). The present data demonstrated that the m.5601C>T variant alters the secondary structure of the tRNAAla gene. Finally, the pathogenicity scoring system generated indicated that the m.5601C>T variant was ‘possibly pathogenic’ (18). Therefore, the mitochondrial dysfunction, caused by the ND4 m. 11778G>A mutation, may be worsened by the m. 5601C>T variant. In conclusion, the m. 5601C>T variant may have a modified role in clinical expression of LHON-associated m. 11778G>A mutation in this family.

Nevertheless, the incomplete penetrance of visual impairment in this family (as evidenced by family members harboring these mutations but exhibiting normal vision) indicated that the ND4 m.11778G>A and tRNAAla m.5601C>T variants are insufficient alone to produce the observed clinical phenotypes. Therefore, it is likely that other risk factors, including environmental factors, nuclear genes and epigenetic modifications, may contribute to the clinical manifestation of LHON in this pedigree. The main limitation of this study is the lack of functional analysis of the tRNAAla m.5601C>T variant. Further studies, such as the use of cytoplasmic hybrid cells carrying the tRNAAla m.5601C>T variant are required to confirm our conclusions and to identify additional contributing risk factors.

 Acknowledgements

Not applicable.

 Funding

The present study was supported by The Hangzhou Health and Family Planning Commission (grant no. 2015A04), The Hangzhou Bureau of Science and Technology (grant no. 20150633B16), The Zhejiang Provincial Administration of Traditional Chinese Medicine (grant no. 2018ZB082) and The Ministry of Public Health from Zhejiang Province (grant nos. 2013KYA158 and 2018ZH019).

 Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

 Authors' contributions

YD and YFY designed the study. MYL and BHX performed the molecular analysis. YFY collected the samples and performed the clinical examinations. JHL analyzed the datasets and carried out the phylogenetic analysis. JHL and YD wrote the paper. All authors discussed the results and implications and commented on the manuscript at all stages. All authors read and approved the final manuscript.

 Ethics approval and consent to participate

The present study was approved by The Ethics Committee of Hangzhou First People's Hospital (Hangzhou, China). Written informed consent was obtained from all participants, or their parent/guardian, prior to enrollment in the study.

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests.

 References Yu-Wai-ManPTurnbullDMChinneryPFLeber hereditary optic neuropathyJ Med Genet39162169200210.1136/jmg.39.3.162118978141735056 CarelliVRugoloMSgarbiGGhelliAZannaCBaraccaALenazGNapoliEMartinuzziASolainiGBioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: A model of mitochondrial neurodegenerationBiochim Biophys Acta1658172179200410.1016/j.bbabio.2004.05.00915282189 PuomilaAHämäläinenPKiviojaSSavontausMLKoivumäkiSHuoponenKNikoskelainenEEpidemiology and penetrance of Leber hereditary optic neuropathy in FinlandEur J Hum Genet1510791089200710.1038/sj.ejhg.520182817406640 Yu-Wai-ManPGriffithsPGBrownDTHowellNTurnbullDMChinneryPFThe epidemiology of Leber hereditary optic neuropathy in the North East of EnglandAm J Hum Genet72333339200310.1086/34606612518276 Yu-Wai-ManPGriffithsPGChinneryPFMitochondrial optic neuropathies-disease mechanisms and therapeutic strategiesProg Retin Eye Res3081114201110.1016/j.preteyeres.2010.11.002211124113081075 JiaXLiSXiaoXGuoXZhangQMolecular epidemiology of mtDNA mutations in 903 Chinese families suspected with Leber hereditary optic neuropathyJ Hum Genet51851856200610.1007/s10038-006-0032-216972023 FraserJABiousseVNewmanNJThe neuro-ophthalmology of mitochondrial diseaseSurv Ophthalmol55299334201010.1016/j.survophthal.2009.10.002204710502989385 MackeyDAOostraRJRosenbergTNikoskelainenEBronte-StewartJPoultonJHardingAEGovanGBolhuisPANorbySPrimary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathyAm J Hum Genet59481485199687559411914749 CatarinoCBAhtingUGusicMIusoAReppBPetersKBiskupSvon LivoniusBProkischHKlopstockTCharacterization of a Leber's hereditary optic neuropathy (LHON) family harboring two primary LHON mutations m.11778G>A and m.14484T>C of the mitochondrial DNAMitochondrion361520201710.1016/j.mito.2016.10.00227721048 YuDJiaXZhangAMGuoXZhangYPZhangQYaoYGMolecular characterization of six Chinese families with m.3460G>A and Leber hereditary optic neuropathyNeurogenetics11349356201010.1007/s10048-010-0236-720232220 AsanadSMeerETianJJFantiniMNassisiMSadunAALeber's hereditary optic neuropathy: Severe vascular pathology in a severe primary mutationIntractable Rare Dis Res85255201910.5582/irdr.2018.01126308818596409112 LiangMJiangPLiFZhangJJiYHeYXuMZhuJMengXZhaoFFrequency and spectrum of mitochondrial ND6 mutations in 1218 Han Chinese subjects with leber's hereditary optic neuropathyInvest Ophthalmol Vis Sci5513211331201410.1167/iovs.13-1301124398099 JiangPLiangMZhangJGaoYHeZYuHZhaoFJiYLiuXZhangMPrevalence of mitochondrial ND4 mutations in 1281 Han Chinese subjects with leber's hereditary optic neuropathyInvest Ophthalmol Vis Sci5647784788201510.1167/iovs.14-1615826218905 RiederMJTaylorSLTobeVONickersonDAAutomating the identification of DNA variations using quality-based fluorescence re-sequencing: Analysis of the human mitochondrial genomeNucleic Acids Res26967973199810.1093/nar/26.4.9679461455147367 AndrewsRMKubackaIChinneryPFLightowlersRNTurnbullDMHowellNReanalysis and revision of the Cambridge reference sequence for human mitochondrial DNANat Genet23147199910.1038/1377910508508 Ruiz-PesiniEWallaceDCEvidence for adaptive selection acting on the tRNA and rRNA genes of human mitochondrial DNAHum Mutat2710721081200610.1002/humu.2037816947981 DingYXiaBHZhangCJZhuoGCMitochondrial tRNALeu(UUR) C3275T, tRNAGln T4363C and tRNALys A8343G mutations may be associated with PCOS and metabolic syndromeGene642299306201810.1016/j.gene.2017.11.04929155328 YarhamJWAl-DosaryMBlakelyELAlstonCLTaylorRWElsonJLMcFarlandRA comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutationsHum Mutat3213191325201110.1002/humu.2157521882289 KongQPBandeltHJSunCYaoYGSalasAAchilliAWangCYZhongLZhuCLWuSFUpdating the East Asian mtDNA phylogeny: A prerequisite for the identification of pathogenic mutationsHum Mol Genet1520762086200610.1093/hmg/ddl13016714301 BibbMJVan EttenRAWrightCTWalbergMWClaytonDASequence and gene organization of mouse mitochondrial DNACell26167180198110.1016/0092-8674(81)90300-77332926 GadaletaGPepeGDe CandiaGQuagliarielloCSbisaESacconeCThe complete nucleotide sequence of the rattus norvegicus mitochondrial genome: Cryptic signals revealed by comparative analysis between vertebratesJ Mol Evol28497516198910.1007/BF026029302504926 RoeBAMaDPWilsonRKWongJFThe complete nucleotide sequence of the xenopus laevis mitochondrial genomeJ Biol Chem2609759977419854019494 QuJLiRZhouXTongYLuFQianYHuYMoJQWestCEGuanMXThe novel A4435G mutation in the mitochondrial tRNAMet may modulate the phenotypic expression of the LHON-associated ND4 G11778A mutationInvest Ophthalmol Vis Sci47475483200610.1167/iovs.05-066516431939 LiRQuJZhouXTongYHuYQianYLuFMoJQWestCEGuanMXThe mitochondrial tRNA(Thr) A15951G mutation may influence the phenotypic expression of the LHON-associated ND4 G11778A mutation in a Chinese familyGene3767986200610.1016/j.gene.2006.02.01416624503 ZhangMZhouXLiCZhaoFZhangJYuanMSunYHWangJTongYLiangMMitochondrial haplogroup M9a specific variant ND1 T3394C may have a modifying role in the phenotypic expression of the LHON-associated ND4 G11778A mutationMol Genet Metab101192199201010.1016/j.ymgme.2010.07.01420728388 QuJLiRZhouXTongYYangLChenJZhaoFLuCQianYLuFGuanMXCosegregation of the ND4 G11696A mutation with the LHON-associated ND4 G11778A mutation in a four generation Chinese familyMitochondrion7140146200710.1016/j.mito.2006.11.01517300996 ZhangJZhouXZhouJLiCZhaoFWangYMengYWangJYuanMCaiWMitochondrial ND6 T14502C variant may modulate the phenotypic expression of LHON-associated G11778A mutation in four Chinese familiesBiochem Biophys Res Commun399647653201010.1016/j.bbrc.2010.07.13520691156 QuJZhouXZhangJZhaoFSunYHTongYWeiQPCaiWYangLWestCEGuanMXExtremely low penetrance of Leber's hereditary optic neuropathy in 8 Han Chinese families carrying the ND4 G11778A mutationOphthalmology116558564200910.1016/j.ophtha.2008.10.022191670852907161 FlorentzCSohmBTryoen-TothPPutzJSisslerMHuman mitochondrial tRNAs in health and diseaseCell Mol Life Sci6013561375200310.1007/s00018-003-2343-112943225 WallaceDCLottMTLeber hereditary optic neuropathy: Exemplar of an mtDNA diseaseHandb Exp Pharmacol240339376201710.1007/164_2017_228233183 WallaceDCSinghGLottMTHodgeJASchurrTGLezzaAMElsasLJIINikoskelainenEKMitochondrial DNA mutation associated with Leber's hereditary optic neuropathyScience24214271430198810.1126/science.32012313201231 ZhangJJiYLuYFuRXuMLiuXGuanMXLeber's hereditary optic neuropathy (LHON)-associated ND5 12338T > C mutation altered the assembly and function of complex I, apoptosis and mitophagyHum Mol Genet2719992011201810.1093/hmg/ddy10729579248 JiYZhangAMJiaXZhangYPXiaoXLiSGuoXBandeltHJZhangQYaoYGMitochondrial DNA haplogroups M7b1′2 and M8a affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G->a mutationAm J Hum Genet83760768200810.1016/j.ajhg.2008.11.002190263972668067 UedaTYotsumotoYIkedaKWatanabeKThe T-loop region of animal mitochondrial tRNA(Ser)(AGY) is a main recognition site for homologous seryl-tRNA synthetaseNucleic Acids Res2022172222199210.1093/nar/20.9.22171375735312334 ZhengPLiSLiuCZhaZWeiXYuanYMitochondrial tRNAAla C5601T mutation may modulate the clinical expression of tRNAMet A4435G mutation in a Han Chinese family with hypertensionClin Exp Hypertens40595600201810.1080/10641963.2017.141149729211511 TanakaMInoHOhnoKOhbayashiTIkebeSSanoTIchikiTKobayashiMWadaYOzawaTMitochondrial DNA mutations in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)Biochem Biophys Res Commun174861868199110.1016/0006-291X(91)91497-Z1899574 DingYTengYSZhuoGCXiaBHLengJHThe mitochondrial tRNAHis G12192A mutation may modulate the clinical expression of deafness-associated tRNAThr G15927A mutation in a Chinese pedigreeCurr Mol Med19136146201910.2174/156652401966619030812155230854964 ZhouHHDaiXNLinBMiHLiuXLZhaoFXZhangJJZhouXTSunYHWeiQPThe analysis of Leber's hereditary optic neuropathy associated with mitochondrial tRNAAla C5601T mutation in seven Han Chinese familiesYi Chuan34103110422012(In Chinese)10.3724/SP.J.1005.2012.0103122917908

A three-generation Han Chinese family pedigree chart of Leber's hereditary optic neuropathy. The arrow indicates the proband (II-12) and filled symbols represent the visually impaired individuals.

Identification of the (A) ND4 m.11778G>A mutation and (B) tRNAAla m.5601C>T variant in the mitochondrial genome. Partial sequence chromatograms of ND4 and tRNAAla genes from the proband (II-12; mutant) and a control subject (wild-type). Arrows indicate the location of the base change. ND4, mitochondrial encoded NADH dehydrogenase 4; tRNAAla, alanine transfer RNA.

Location of the tRNAAla m.5601C>T variant. The secondary structure of tRNAAla protein (wild-type) was derived from the Mitomap database (www.mitomap.org). Arrow indicates the m.5601C>T variant. tRNAAla, alanine-transfer RNA.

Predicted secondary protein structure of tRNAAla with (mutant) and without (wild-type) the m.5601C>T variant (indicated by arrow). The RNA Fold Webserver program (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi) was used to predict the structure. The structure is colored according to the base-pairing probability (0-1, as denoted in the color scale bar).

Mitochondrial DNA sequence accession number of 17 vertebrate species used in the phylogenetic analyses.

Species GenBank accession no.
Homo sapiens NC_012920
Cebus albifron NC_002763
Gorilla gorilla NC_011120
Hylobates lar NC_002082
Lemur catta NC_004025
Macaca mulatta NC_005943
Macaca sylvanus NC_002764
Nycticebus coucang NC_002765
Pan paniscus NC_001644
Pan troglodytes NC_001643
Papio hamadryas NC_001992
Pongo pygmaeus NC_001646
Pongo pygmaeus abelii NC_002083
Tarsius bancanus NC_002811
Mus musculus NC_006914.1
Bos taurus HM045018.1
Xenopus laevis NC_001573.1

Summary of the clinical data for the proband (II-12) and matrilineal relatives (II-5, II-7 and III-8) in the Han Chinese family with maternally inherited Leber's hereditary optic neuropathy.

Visual impairment score
Subject Sex Age at onset (years) Age at test (years) Right eye Left eye Degree of visual impairmenta
II-5 Male 11 35 0.03 0.05 Severe
II-7 Male 16 33 0.1 0.2 Moderate
II-12 Female 19 39 0.01 0.01 Profound
III-8 Male   3   7 0.02 0.01 Profound

The degree of visual impairment was classified based on criteria stated in the clinical examinations section of the Methods.

Sequence analysis of mitochondrial DNA mutations in a Han Chinese family with maternally inherited Leber's hereditary optic neuropathy.

Gene Position Base change Conservation (H/B/M/X)a CI (%) Previously reportedb
D-loop 73 A>G Yes
152 T>C Yes
189 A>C Yes
263 A>G Yes
489 T>C Yes
16117 T>C Yes
16172 T>C Yes
16223 T>C Yes
16519 T>C Yes
12S rRNA 709 G>A G/A/A/- Yes
1438 A>G A/A/A/G Yes
16S rRNA 2706 A>G A/G/A/A Yes
ND1 3593 T>C (p.V96A) V/I/I/A 25 Yes
4102 Yes
ND2 4769 A>G Yes
4833 A>G Yes
5108 T>C Yes
5442 T>C (p. F325L) F/F/M/L 23 Yes
tRNAAla 5601 C>T C/C/C/C 100 Yes
CO1 7028 C>T Yes
7600 G>A Yes
CO2 8167 C>T Yes
ATP6 8547 C>T Yes
8748 C>T Yes
9103 T>C (p. F193L) F/F/F/S 52 Yes
ND3 10398 A>G (p. T114A) T/T/T/A 36 Yes
ND4 11719 G>A Yes
11778 G>A (p. R340H) R/R/R/R 100 Yes
ND5 12705 C>T Yes
ND6 14668 C>T Yes
Cyt b 15043 G>A Yes
15301 G>A Yes

Conservation of amino acid for polypeptide.

From Mitomap database (www.mitomap.org). Conserved nucleotide residues are shown in bold font. B, bovine; CO, cytochrome c oxidase; cyt b, cytochrome b; H, human; M, mouse; ND, mitochondrial encoded NADH dehydrogenase; rRNA, ribosomal RNA; tRNA, transfer RNA; X, Xenopus laevis.

Clinical and molecular data for eight Han Chinese pedigrees carrying the ND4 11778G>A primary mutation in LHON.

Author, year Pedigree number Affected ratio (male:female) Penetrance of LHON (%) Secondary variants MthNA haplogroup (Refs.)
Ding et al, 2019 1 3:1 40 tRNAAla m.5601C>T B5b1 –
Qu et al, 2006 2 3:1 61.5 tRNAMet m.4435A>G D5 (23)
Li et al, 2006 3 2:1 60 tRNAThr m.15951A>G D4 (24)
Zhang et al, 2010 4 3:0 37.5 ND1 m.3394T>C M9a (25)
Qu et al, 2007 5 3.5:1 33 ND4 m.11696G>A D4 (26)
Zhang et al, 2010 6 1:1 57.1 ND6 m.14502T>C M10a (27)
Qu et al, 2009 7 1:0 14.2 None M8a2 (28)
Qu et al, 2009 8 2:0 8 None D4g2 (28)

LHON, Leber's hereditary optic neuropathy; ND, mitochondrial encoded NADH dehydrogenase; tRNA, transfer RNA.

Pathogenicity scoring system for the m.5601C>T mutation.

Scoring criteria m.5601C>T mutation Score Classification
More than one independent report Yes 2
Evolutionary conservation of the base pair No changes 2
Variant heteroplasmy No 0
Segregation of the mutation with disease Yes 2
Histochemical evidence of mitochondrial disease Strong evidence 2
Biochemical defect in complex I, III or IV No 0
Evidence of mutation segregation with biochemical defect from single-fiber studies No 0
Mutant mt-tRNA steady-state level or evidence of pathogenicity in trans-mitochondrial cybrid studies No 0
Total score 8 Possibly pathogenic